How we judged value
Value here means what a system delivers (health outcomes, access, fairness and efficiency) relative to what it spends. We use published sources only: the Commonwealth Fund's Mirror, Mirror 2024 rankings and World Bank data on spending and life expectancy. We do not invent scores. Where the sources do not cover a country or a question, we say so.
Health spending per person vs life expectancy
What "healthcare value" means
A system can be excellent and expensive, or cheap and poor. Value is the relationship between the two. To judge it, you need both sides of the equation from sources you can check:
- What goes in: health spending, measured per person and as a share of the economy.
- What comes out: outcomes, such as how long people live and how many avoidable deaths occur, plus how easily people get care, how fairly it is shared and how much effort is lost to administration.
No single published index combines all of this for every country. So this verdict combines two sources: a detailed comparison of ten wealthy countries, and simpler spending and life-expectancy data that let us add Colombia.
Verdict 1: among wealthy countries, Australia and the Netherlands
The Commonwealth Fund's Mirror, Mirror 2024 ranks ten high-income countries on 70 measures. Its top three overall were Australia, the Netherlands and the United Kingdom. On health outcomes specifically, Australia, Switzerland and New Zealand performed best.
The report is explicit that spending is not one of its performance measures. It does give spending as context, noting that the Netherlands and Australia have the lowest health spending as a share of GDP among the ten. Put those two facts together and the value verdict among rich countries is clear: Australia and the Netherlands get top-ranked performance from the smallest relative budgets in the group.
The United Kingdom deserves an honourable mention. It placed third overall, and World Bank data show it spends less per person than Australia, the Netherlands or Canada. Its well-known weakness, waiting times, is real. But on overall performance per dollar, it is one of the stronger systems in this group.
Verdict 2: the United States loses on value
The US ranked last overall and last on health outcomes in the 2024 comparison. The Commonwealth Fund notes that the US spent more than 16% of GDP on health care in 2022 and is projected to pass 20% by 2035. World Bank data put US spending at about $13,473 per person in 2023, roughly double Australia's, the Netherlands' or Canada's, and more than twenty times Colombia's.
| Country | Spending per person (US$) | Spending as % of US level | Life expectancy, 2024 |
|---|---|---|---|
| United States | 13,473 (2023) | 100% | 78.9 |
| Australia | 6,980 (2023) | 52% | 83.1 |
| Netherlands | 6,845 (2024) | 51% | 82.0 |
| Canada | 6,378 (2024) | 47% | 82.1 |
| United Kingdom | 5,860 (2024) | 43% | 81.4 |
| Colombia | 644 (2024) | 5% | 77.9 |
Source: World Bank World Development Indicators, current health expenditure per capita and life expectancy at birth (accessed October 2026). Percentages calculated by HealthcareCompare and rounded. Spending years differ.
Every other high-income country in the table has a longer life expectancy than the US, and all four do it on roughly half the spending or less. This is the core of the US value problem. For more on what that spending buys, see our analysis of US spending per capita.
Verdict 3: Colombia gets the most life expectancy per dollar in this group
Colombia is not in the Commonwealth Fund comparison, so it has no score on access, equity or administrative efficiency from that source. On the simpler measures, the result is striking. Colombia spends about $644 per person, about 5% of the US level, and its life expectancy of 77.9 years is about one year below the US figure.
Put another way, the US spends about twenty dollars on health for every dollar Colombia spends per person, and gains roughly one extra year of life expectancy. Even allowing for differences in data years, that gap is too large to explain away. It supports calling Colombia a high-value system at the population level, with three important caveats:
- Life expectancy is a blunt measure. It reflects income, safety, diet and much else besides healthcare.
- National averages hide gaps. Access and quality differ between major cities and rural areas.
- Foreign patients use a different market. International patients usually pay private hospitals directly. Their prices and experience are not captured by national spending figures. For a direct two-country view, read US vs Colombia healthcare: cost and quality.
Value depends on who is asking
The same system can look like a bargain or a poor deal depending on whose money and whose health you are counting.
| Viewpoint | What counts as value | Most useful evidence |
|---|---|---|
| A country or taxpayer | Population health and fairness for the money spent | Spending per person and as a share of GDP, outcomes, equity rankings |
| A resident patient | Getting needed care quickly without financial hardship | Access measures, waiting times, out-of-pocket costs and coverage rules |
| A foreign patient | A safe result at a total cost and timeline that beat the options at home | Hospital-level quality evidence, an itemised quote, aftercare plans |
The country-level verdicts above answer the first row. They are only background for the third row, which is the question most people reading a "which country wins" article are really asking.
Why there is no single winner for you
System value and personal value are different things. A system can be excellent value for its own residents and still be the wrong choice for you, because you may not be eligible, may face a waiting list, or may need a procedure it does not cover. Three questions turn the national verdict into a personal one:
- What do you need? Ongoing care for a chronic condition favours a system you can actually join. A single planned procedure opens up options abroad.
- What would you pay? Your own costs, including premiums, deductibles, travel and aftercare, matter more than national averages.
- How much does time matter? If a long wait carries real costs for your health or income, a faster, self-paid option may be better value for you even in a system that ranks well.
For a structured way to weigh rankings against each other, see how healthcare system comparisons are measured. For a wider multi-dimension scorecard covering 15 countries, see the Global Healthcare Scorecard 2026.
The Takeaway
Among wealthy countries, Australia and the Netherlands win on value: top-ranked performance at the lowest relative spending. The US loses on value despite world-leading spending. Colombia delivers the most life expectancy per dollar in our comparison, with clear caveats. For your own decision, weigh what you need, what you would personally pay and how much time matters.
Frequently Asked Questions
Which country has the best healthcare value in 2026?
Among high-income countries, Australia and the Netherlands stand out. They ranked first and second overall in the Commonwealth Fund's 2024 comparison and had the lowest health spending as a share of GDP among the ten countries studied.
Why does the US rank last when it spends the most?
Value compares results with spending. The US ranked last overall and last on health outcomes in the 2024 comparison, while spending about $13,473 per person in 2023, roughly twice as much as most peers, according to World Bank data.
Is Colombia's healthcare system good value?
At the population level, it shows strong value. World Bank data show spending of about $644 per person with life expectancy of 77.9 years, close to the US. Life expectancy is a blunt measure, though, and averages hide regional differences.
Does the best-value system mean the best place to have surgery?
No. National value measures describe whole systems for their residents. For a specific procedure, what matters is the individual hospital and surgeon, your eligibility, waiting times and the total cost to you.
Where does the UK rank on healthcare value?
The UK placed third overall in the Commonwealth Fund's 2024 ranking and spends less per person than Australia, the Netherlands or Canada, according to World Bank data. Waiting times are its most discussed weakness.
Get a Personalized Comparison
Tell us your specific situation and priorities and we'll help you think through the right option.
Ask Us a Question